Fundz

Alfasigma Completes Acquisition Of Intercept Pharmaceuticals, Inc.

Nov 08, 2023

Acquiring Company

Alfasigma

Acquired Company

Intercept Pharmaceuticals

BolognaMorristownManufacturingBiotechnologyHealth Care

Description

Alfasigma S.p.A. (“Alfasigma”) and Intercept Pharmaceuticals, Inc. (“Intercept”) announced today the completion of the acquisition of Intercept by Alfasigma through its wholly owned subsidiary Interstellar Acquisition Inc.

Who to call at Alfasigma, and when

When Alfasigma changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Alfasigma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Alfasigma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Alfasigma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Alfasigma

Location

Bologna, Emilia Romagna, Italy

About

Alfasigma is one of Italy's leading pharmaceutical companies with a strong international position. The Group has a worldwide presence in over 100 countries where about 3000 people work in research, development, production and distribution. In Italy, Alfasigma is a leader in the prescription products market where, in addition to its strong focus on gastro-intestinal products, it is present in several primary care therapeutic areas. It is popular with the consumer public for a number of nutraceuticals & food supplements that respond to different needs, and that are well known and deeply rooted in the Italian families experience. Its historical headquarters is in Bologna, to which is added Milan, while the production sites are: in Italy, in Pomezia (RM), Alanno (PE), Sermoneta (LT) and Trezzano Rosa (MI) and abroad in Tortosa in Spain and in Shreveport (Louisiana) in the United States. The R&D laboratories are in Pomezia and in the Parco Scientifico Tecnologico Kilometro Rosso in Bergamo. Alfasigma's mission is to improve people's health and quality of life by offering caregivers and healthcare personnel therapeutic solutions according to the highest standards of quality and safety.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Alfasigma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Flaminia
Senior decision-maker at this company
••••••••@••••••••

See Flaminia's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Alfasigma's next move

Learn about Strategic plan

Frequently asked

Who acquired Intercept Pharmaceuticals?

Intercept Pharmaceuticals was acquired by Alfasigma, based in Bologna. The deal was reported on November 8, 2023. Alfasigma is one of Italy's leading pharmaceutical companies with a strong international position. Alfasigma is privately held and operates in Manufacturing.

When did Alfasigma acquire Intercept Pharmaceuticals?

Alfasigma's acquisition of Intercept Pharmaceuticals was reported on November 8, 2023. Alfasigma S.p.A. (“Alfasigma”) and Intercept Pharmaceuticals, Inc. (“Intercept”) announced today the completion of the acquisition of Intercept by Alfasigma through its wholly owned subsidiary Interstellar Acquisition Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Intercept Pharmaceuticals do?

We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, including primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). It is privately held, and is based in Morristown.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.